• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors”.
    No. Publication Date Citing Article
    1 2020 Robert I. Troup, Charlene Fallan, Matthias G. J. Baud. Current strategies for the design of PROTAC linkers: a critical review, Exploration of Targeted Anti-tumor Therapy. 2020; 1:   https://doi.org/10.37349/etat.2020.00018
    2 2021 Ota Fuchs, Radka Bokorova. Preclinical Studies of PROTACs in Hematological Malignancies, Cardiovascular & Hematological Disorders-Drug Targets . 2021; 21: 7.  https://doi.org/10.2174/1871529X21666210308111546
    3 2021 Moritz Fürstenau, Barbara Eichhorst. Novel Agents in Chronic Lymphocytic Leukemia: New Combination Therapies and Strategies to Overcome Resistance, Cancers. 2021; 13: 1336.  https://doi.org/10.3390/cancers13061336
    4 2022 Rachael Arthur, Alexander Wathen, Elizabeth A. Lemm, Freda K. Stevenson, Francesco Forconi, Adam J. Linley, Andrew J. Steele, Graham Packham, Beatriz Valle-Argos. BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cells, Cellular Signalling. 2022; 96: 110358110358.  https://doi.org/10.1016/j.cellsig.2022.110358
    5 2022 Jingyu Zhang, Jinxin Che, Xiaomin Luo, Mingfei Wu, Weijuan Kan, Yuheng Jin, Hanlin Wang, Ao Pang, Cong Li, Wenhai Huang, Shenxin Zeng, Weihao Zhuang, Yizhe Wu, Yongjin Xu, Yubo Zhou, Jia Li, Xiaowu Dong. Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton’s Tyrosine Kinase for the Treatment of Lymphoma, Journal of Medicinal Chemistry. 2022; 65: 9096.  https://doi.org/10.1021/acs.jmedchem.2c00324
    6 2023 Manvendra Kumar, Joydeep Chatterjee, Dimpy Rani, Raj Kumar. 2023; 117.  https://doi.org/10.1016/B978-0-443-18616-5.00006-5
    7 2024 Raffaele Sciaccotta, Sebastiano Gangemi, Giuseppa Penna, Laura Giordano, Giovanni Pioggia, Alessandro Allegra. Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis, Antioxidants. 2024; 13: 475.  https://doi.org/10.3390/antiox13040475
    8 2022 Ota Fuchs, 2022; 71.  https://doi.org/10.1016/B978-0-323-90042-3.15001-7
    9 2023 Yi-Qian Li, William G. Lannigan, Shabnam Davoodi, Fereidoon Daryaee, Ana Corrionero, Patricia Alfonso, Jose A. Rodriguez-Santamaria, Nan Wang, John D. Haley, Peter J. Tonge. Discovery of Novel Bruton’s Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy, Journal of Medicinal Chemistry. 2023; 66: 7454.  https://doi.org/10.1021/acs.jmedchem.3c00176
    10 2023 Ana Portelinha, Hans-Guido Wendel. The cat-and-mouse game of BTK inhibition, Blood. 2023; 141: 1502.  https://doi.org/10.1182/blood.2022018936
    11 2022 Matthew R. Burke, Alexis R. Smith, Guangrong Zheng. Overcoming Cancer Drug Resistance Utilizing PROTAC Technology, Frontiers in Cell and Developmental Biology. 2022; 10: 872729.  https://doi.org/10.3389/fcell.2022.872729
    12 2023 Deyi Zhang, Hailey M. Harris, Jonathan Chen, Jen Judy, Gabriella James, Aileen Kelly, Joel McIntosh, Austin Tenn-McClellan, Eileen Ambing, Ying Siow Tan, Hao Lu, Stefan Gajewski, Matthew C. Clifton, Stephanie Yung, Daniel W. Robbins, Mehdi Pirooznia, Sigrid S. Skånland, Erika Gaglione, Maissa Mhibik, Chingiz Underbayev, Inhye E. Ahn, Clare Sun, Sarah E. M. Herman, Mark Noviski, Adrian Wiestner. NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts, Blood. 2023; 141: 1584.  https://doi.org/10.1182/blood.2022016934
    13 2022 Guangyan Du, Jie Jiang, Nathaniel J. Henning, Nozhat Safaee, Eriko Koide, Radosław P. Nowak, Katherine A. Donovan, Hojong Yoon, Inchul You, Hong Yue, Nicholas A. Eleuteri, Zhixiang He, Zhengnian Li, Hubert T. Huang, Jianwei Che, Behnam Nabet, Tinghu Zhang, Eric S. Fischer, Nathanael S. Gray. Exploring the target scope of KEAP1 E3 ligase-based PROTACs, Cell Chemical Biology. 2022; 29: 1470.  https://doi.org/10.1016/j.chembiol.2022.08.003
    14 2021 Joel O. Cresser-Brown, Graham P. Marsh, Hannah J. Maple. Reviewing the toolbox for degrader development in oncology, Current Opinion in Pharmacology. 2021; 59: 43.  https://doi.org/10.1016/j.coph.2021.04.009